Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Benchmark Holdings annual loss widens; sets returns from Genetics sale

12th Dec 2024 11:10

(Alliance News) - Benchmark Holdings PLC on Thursday said it is in a position to realise the potential of its two remaining business areas, Advanced Nutrition and Health, as it posted a widened annual loss.

The Sheffield, England-based company offers products and services that enable aquaculture producers to improve their productivity and sustainability.

Its pretax loss widened to GBP45.9 million in the financial year ended September 30 from GBP24.7 million the year before, as revenue fell 13% to GBP147.7 million from GBP169.7 million.

Chief Executive Officer Trond Williksen said: "The sale of Genetics creates an opportunity to simplify the group's structure, positioning it to realise the potential in the Advanced Nutrition and Health business areas, whilst reducing costs and leverage. At the same time it will enable a return of capital to shareholders. Following the disposal, Benchmark will become a lean, profitable organisation with a solid balance sheet, focused on realising the significant value and potential in our continuing business where we have market leading positions, a track record of innovation and significant headroom for growth."

Last month, Benchmark announced the sale of Benchmark Genetics Ltd and Benchmark Genetics Norway AS to Starfish Bidco AS, a wholly owned subsidiary of Novo Holdings AS, for an enterprise value of up to GBP260 million.

On Thursday, Benchmark said it expects the disposal to complete in the first quarter of next year. It will use the sale proceeds to pay down debt and return money to shareholders. Net debt was GBP49.0 million on September 30, down from GBP65.5 million a year before, as GBP22.3 million in debt will be transferred with the Genetics business.

Separately, Benchmark said it has appointed Tripp Lane as chair from next week Tuesday, as Peter George will retire.

Lane is a founding partner of Delancey Cove LLC, an advisory firm focused on transitional governance and management of private and public companies.

Benchmark shares were down 3.2% to 33.20 pence on Thursday morning in London.

By Tom Budszus, Alliance News slot editor

Comments and questions to [email protected]

Copyright 2024 Alliance News Ltd. All Rights Reserved.

FTSE 100 Latest
Value8,314.13
Change12.51